Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis.
OBJECTIVE
To determine whether platelets are hyperaggregable or form platelet-neutrophil aggregates during the prodromal stages of acute laminitis of ponies.


METHODS
Healthy adult ponies: 8 experimental and 6 control.


METHODS
Acute laminitis was induced by oral administration of corn starch and wood flour to 8 ponies, and indices of platelet activation were evaluated. Blood samples were collected before and at 4, 8, 12, 24, 28, and 32 hours after carbohydrate administration, and PCV, total plasma protein concentration, platelet count, activated clotting time, whole blood recalcification time, spontaneous platelet aggregation, ex vivo platelet aggregation responses, and platelet-neutrophil aggregates were determined. When lameness was first detected, ponies were euthanatized and arteriography and histologic examination of hooves were performed.


RESULTS
Carbohydrate overload was associated with hyperaggregability of platelets throughout the prodromal stages of laminitis and increased numbers of platelet-neutrophil aggregates. Reduction of blood supply to affected hooves was variable, and blood clots were found in 6 of 11 laminitis-affected hooves.


CONCLUSIONS
Platelets were hyperaggregable throughout the prodromal stages of carbohydrate-induced laminitis and formed platelet-neutrophil aggregates. Platelet-neutrophil aggregates may initiate or contribute to development of acute laminitis.


CONCLUSIONS
Anti-platelet therapy may be useful for treatment of acute alimentary laminitis in horses.
Weiss
D J
DJ
Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul 55108, USA.
Evanson
O A
OA
McClenahan
D
D
Fagliari
J J
JJ
Jenkins
K
K
D000208:Acute Disease; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001485:Basement Membrane / Q000502:physiology / Q000648:ultrastructure; D001777:Blood Coagulation / Q000502:physiology; D001792:Blood Platelets / Q000473:pathology* / Q000502:physiology; D002449:Cell Aggregation; D004040:Dietary Carbohydrates / Q000009:adverse effects; D005260:Female; D005534:Foot Diseases / Q000097:blood / Q000209:etiology / Q000662:veterinary*; D006724:Hoof and Claw; D006734:Horse Diseases / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D006736:Horses; D008297:Male; D009504:Neutrophils / Q000473:pathology* / Q000502:physiology; D015539:Platelet Activation / Q000502:physiology*; D010974:Platelet Aggregation / Q000187:drug effects / Q000502:physiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D004040:Dietary Carbohydrates; D010975:Platelet Aggregation Inhibitors; D000244:Adenosine Diphosphate